The order of mutation acquisition can influence the MPN phenotype; mutations in TET2 arising prior to JAK2V617F favors the ET phenotype, but the acquisition of JAK2V617F in a TET2 non-mutated background is more likely to result in the PV phenotype [125]. Here, TET2 is linked to myeloproliferative neoplasm.